Evolus Revenue and Competitors

Location

$310.5M

Total Funding

Estimated Revenue & Valuation

  • Evolus's estimated annual revenue is currently $30.1M per year.(i)
  • Evolus's estimated revenue per employee is $114,885
  • Evolus's total funding is $310.5M.

Employee Data

  • Evolus has 262 Employees.(i)
  • Evolus grew their employee count by 7% last year.

Evolus's People

NameTitleEmail/Phone
1
Executive Director, AccountingReveal Email/Phone
2
Chief Marketing OfficerReveal Email/Phone
3
VP CreativeReveal Email/Phone
4
General Counsel and Corporate SecretaryReveal Email/Phone
5
SVP SalesReveal Email/Phone
6
SVP, Corporate DevelopmentReveal Email/Phone
7
VP and General Manager, EvolusReveal Email/Phone
8
VP, Head Global Medical AffairsReveal Email/Phone
9
SVP Digital Marketing and InnovationReveal Email/Phone
10
VP Regulatory AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A13386-6%N/AN/A
#2
$5.2M45N/AN/AN/A
Add Company

What Is Evolus?

Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. At Evolus, you have the opportunity to be part of a movement. A performance beauty company changing the game. We are bringing innovation and forward-thinking technology to an industry desperately wanting frictionless experiences. Our work disrupts the status quo, but most importantly, we will make an impact, we are customer-centric - always. Because of this, we are excited to step through the door each morning. We help each other climb; we don't climb over one another. We believe that integrity and a team-driven environment connect entrepreneurial minds. Getting goose bumps Good. Join the Evolus movement, and let's see where you can put your talents to work.

keywords:Health and Wellness

$310.5M

Total Funding

262

Number of Employees

$30.1M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Evolus News

2022-04-13 - -$0.41 Earnings Per Share Expected for Evolus, Inc ...

Equities research analysts forecast that Evolus, Inc. (NASDAQ:EOLS – Get Rating) will report earnings of ($0.41) per share for the current...

2022-04-06 - Evolus Inc (EOLS) is down -0.80% in a Week, Should You Sell?

Evolus Inc also received an overall rating of 62, putting it above 62% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 141 out...

2022-03-30 - Evolus Announces First Patient Enrolled in Phase II Clinical ...

Evolus (Nasdaq: EOLS) is a performance beauty company with a customer-centric approach to delivering breakthrough products.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$78.1M2633%N/A
#2
$35M27237%N/A
#3
$54.5M275N/AN/A
#4
$15M277N/AN/A
#5
$82.9M27921%N/A